<ѻýҕl>Modest Risks Come With Moving Fast on HF Drugs After Acute Eventѻýҕl> STRONG-HF analysis details the impact Oct 10, 2023
<ѻýҕl>Vagus Nerve Stimulation in Limbo for HFrEFѻýҕl> Autonomic regulation therapy trial showed signal for benefit in terminated pivotal trial Oct 09, 2023
<ѻýҕl>Biomarker-Based CardioMEMS Candidates Still Benefitѻýҕl> GUIDE-HF trial analysis distinguishes "strata" with different levels of risk Oct 09, 2023
<ѻýҕl>FDA Turns Down ATTR Cardiomyopathy Drugѻýҕl> Decision cites insufficient evidence of clinical meaningfulness Oct 09, 2023
<ѻýҕl>Novel Agent Promising as Add-On Epilepsy Treatmentѻýҕl> Phase IIb trial shows benefit for the most common type of epileptic seizures Oct 09, 2023
<ѻýҕl>Weight-Loss Drug Benefit Spans HFpEF, HFmrEFѻýҕl> STEP-HFpEF trial results come out consistent across ejection fraction Oct 08, 2023
<ѻýҕl>Managing Heart Failure Comorbiditiesѻýҕl> Hypertension, atrial fibrillation, type 2 diabetes, and anemia care may require adjustment in HF Oct 02, 2023
<ѻýҕl>For Your Patients: Managing Heart Failure With Other Chronic Conditionsѻýҕl> Having a combination of HF and other medical issues can impact how you approach each of them Oct 02, 2023
<ѻýҕl>No Benefit to Tight Glucose Control in ICUѻýҕl> Trial attempts to settle the controversy once and for all Sep 29, 2023
<ѻýҕl>FDA Panel Favors Dropping OTC Decongestantѻýҕl> Unanimous vote that the drug is ineffective Sep 12, 2023